Income Taxes (Tables)

12 Months Ended

Dec. 31, 2022

Income Tax Disclosure [Abstract]

Schedule of deferred tax assets

	As of December 31,
	2022			2021
Current:
Accrued expenses	$	133,591		$	144,077
Stock compensation		354,274			1,800,762
Net operating loss carryforward		20,980,803			19,481,137
Research and development credit carry forward		1,340,317			252,536
Capitalized research and development		1,419,818			-
Total deferred tax assets		24,228,803			21,678,512
Valuation allowance		(24,228,803	)		(21,678,512	)
Deferred tax asset, net of valuation allowance	$	-		$	-

Schedule of federal income tax rate to effective tax rate

	For the Years Ended December 31,
	2022			2021
U.S. statutory federal rate		21.0	%		21.0	%
State income taxes, net of federal tax		7.1	%		7.0	%
Permanent differences		0.1	%		(2.5	)%
Prior year true-ups		(10.9	)%		(2.7	)%
R&D tax credit		3.7	%		0.1	%
Change in valuation allowance		(21.0	)%		(22.9	)%
Income tax provision (benefit)		-	%		-	%

Schedule of income tax provision consists

	For the Years Ended December 31,
	2022			2021
Federal
Current	$	-		$	-
Deferred		(1,909,246	)		(2,723,112	)
State and local
Current		-			-
Deferred		(641,044	)		(905,577	)
Change in valuation allowance		2,550,290			3,628,689
Income tax provision (benefit)	$	-		$	-